Transcatheter heart valves technologies

Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis

Published on 05/01/2023 | Isabel A. Hoerbrand 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.14262 | 21 minute read

Abstract Aims Wildtype transthyretin amyloid cardiomyopathy is an under‐recognized cause of heart failure in elderly patients. Transcatheter tricuspid valve repair

Transcatheter heart valves technologies

Multicenter experience with valve‐in‐valve transcatheter aortic valve replacement compared with primary, native valve transcatheter aortic valve replacement

Published on 15/12/2022 | Michael P. RobichMD 1 et al. | Journal of Cardiac Surgery 2022; AOP: 10.1111/jocs.17084 | 16 minute read

Abstract Background Valve‐in‐valve (ViV) transcatheter aortic valve replacement (TAVR) offers an alternative to reoperative surgical aortic valve replacement. The short‐

Transcatheter heart valves technologies

2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses

Published on 15/12/2022 | Eleid et al. | Journal of the American College of Cardiology 2022; 80(23): 2171-83 | 0 minute read

Transcatheter heart valves technologies

Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?

Published on 01/12/2022 | Elena Di Pietro et al. | European Heart Journal Supplement 2022; 24(Supplement_I): I170 | 13 minute read

Abstract New insights into the natural history and pathophysiology of patients with aortic stenosis (AS), coupled with the dramatic evolution

Transcatheter heart valves technologies

Feasibility of transcaval access TAVI in morbidly obese patients: A single‐center experience

Published on 17/11/2022 | Michael Michail et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30465 | 11 minute read

Abstract Objectives We report a single‐center experience in utilizing the transcaval‐access transcatheter aortic valve implantation (TAVI) as an alternative approach

Transcatheter heart valves technologies

Use of Virtual Reality for procedural planning of Transcatheter Aortic Valve Replacement

Published on 17/11/2022 | Xavier Ruyra et al. | Interactive CardioVascular and Thoracic Surgery 2022; aop: 10.1093/icvts/ivac248 | 1 minute read

Abstract This study sought to evaluate the impact of Virtual Reality (VR) tools in procedural planning of transcatheter aortic

Transcatheter heart valves technologies

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Published on 03/11/2022 | Mark Lachmann 1 et al. | Open Heart 2022; 9(2): e002068 | 30 minute read

Abstract Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic

Transcatheter heart valves technologies

Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database

Published on 20/10/2022 | Waqas Ullah MD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30407 | 22 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) has increasingly been utilized in patients with bicuspid aortic valve (BAV) related aortic

Transcatheter heart valves technologies

The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties

Published on 20/10/2022 | Jurrien ten Berg et al. | European Heart Journal 2022; aop: 10.1093/eurheartj/ehac385 | 49 minute read

Abstract Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure, which is used frequently in patients with symptomatic severe

Transcatheter heart valves technologies

Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR From the ALIGN-TAVR Consortium

Published on 06/10/2022 | Tang et al. | JACC. Cardiovascular interventions 2022; 15(15): 1497-518 | 0 minute read

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.